Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer
ClinicalTrials.gov study NCT00191789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
ClinicalTrials.gov study NCT00226590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer
ClinicalTrials.gov study NCT03807999. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01470417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
ClinicalTrials.gov study NCT04203160. IPD Sharing: NO. Countries: 1. Publications: 0.
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
ClinicalTrials.gov study NCT02611037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
ClinicalTrials.gov study NCT01958580. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00191451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
ClinicalTrials.gov study NCT00496587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02017015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT00523640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00625586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
ClinicalTrials.gov study NCT00227721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02383433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
ClinicalTrials.gov study NCT02365766. IPD Sharing: NO. Countries: 1. Publications: 0.
A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00652366. IPD Sharing: Not stated. Countries: 23. Publications: 0.
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT00100789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT00630409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00894504. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
ClinicalTrials.gov study NCT00478361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.